Lung DC‐T immunity hub in immune surveillance: new concepts and future directions DOI Creative Commons
Juan Liu,

Boyi Cong,

Xuetao Cao

и другие.

Cancer Communications, Год журнала: 2024, Номер unknown

Опубликована: Дек. 17, 2024

An effective coordination of immune and non-immune cells is essential for generating optimal regional immunity to combat tumorigenesis infection at barrier tissues such as lung. Regional structures inducible bronchus-associated lymphoid tissue (iBALT) tertiary structure (TLS) play roles in modulating lung local responses. While the identification iBALTs or TLS generally dependent on conventional histology, it remains poorly understood how are spatiotemporally coordinated single-cell resolution effectively eliminate malignant invading pathogens. Recently studies have revealed presence dendritic cell (DC)-T hubs human with close association tumor immunotherapy response [1], antiviral [2], inflammation [3]. The DC-T delineates pulmonary multicellular networks level antitumor response, will profound implications diagnosis treatment cancer infection. integration technologies high-resolution spatial imaging methods has been applied reveal landscapes microenvironment (TME) relevance caner development, clinical outcome, therapy responsiveness [4]. Multicellular C-X-C motif chemokine ligand 13-positive (CXCL13+) T interferon-stimulated gene (ISG)-expressing myeloid detected luminal surface colorectal [5]. same group further existence hub [1]. This composed activated CCR7+ lysosomal-associated membrane protein 3-positive (LAMP3+) DCs (also termed mature enriched regulatory molecules, mregDCs), stem-like transcription factor 7-positive (TCF7+) programmed death 1-positive (PD-1+) CD8+ cells, C-C 19-positive (CCL19+) fibroblasts, strongly associate beneficial outcome PD-1 blockade therapy. Chemokine adhesion pathways stability organization hub, consistence report that leukocyte molecule, CD6 (ALCAM/CD166) stabilizes DC-CD8 interactions early stages against evasion [6]. intratumoral niche consisting mregDCs, CXCL13+CD4+ helper progenitor also present hepatocellular carcinoma associates [7]. combination RNA sequencing (scRNA-seq) significantly facilitated cellular molecular immunological niches transcriptional levels, multiplexed allows characterization levels. One study using imaging, quantitative analysis, machine learning mapped tumors mice human, identified interacting lymphocytes ("lymphonets") a distinctive feature anti-cancer response. Such lymphnets contain TCF1+PD-1+CD8+ progenitors gain cytotoxic populations enhance anti-tumor responses [8]. It should be noted can remodeled by TME promote malignancy metastasis [9]. recent advanced multiplex techniques discovered mregDC recruit (Tregs) form mregDC-Treg around lymphatic vessels peripheral stroma. peri-lymphatic prevents antigen trafficking draining lymph nodes (dLNs), thus inhibits promotes progression [10]. Similarly, LAMP3+ DC expressing indoleamine 2,3-dioxygenase 1 (IDO1) was shown interact exhausted CD4+ Treg cervical cancers (CC), inhibiting IDO1 could efficacy checkpoint mouse model CC [11]. Further elucidating mechanisms education reprograming versus pro-tumor novel targets screening, diagnosis, treatment. Although multiple analyzed underlying caused severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) [12], few about along entire process In study, Cong et al. [2] integrated enhanced omics-sequencing (Stereo-seq) scRNA-seq specific containing three co-localized subset, Cd160+Cd8+ necrosis receptor superfamily, member 4 (Tnfrsf4)+Cd4+ 7 (Ccr7)+Ido1+ which dynamically shapes host SARS-CoV-2 (Figure 1). Chemokines, co-stimulatory factors molecules critical intercellular communication among components, emphasizing active chemotaxis adhesive after viral localizes alveoli, provides first defense microbial alveolar region, distinguished from gut-associated (GALTs) only reside deeper organs (Supplementary Table S1). rapid day first-line infection, challenging traditional idea cell-mediated adaptive requires 5∼7 days take place post addition, proliferation potent interaction between SLAM family 9 (Slamf9)+ macrophage important clearance SARS-CoV-2. virally infected Slamf9+ macrophages highly express remodeling angiogenesis genes, implying their involvement remodeling. As late 14 differentiate toward triggering expressed (Trem2)+ fructose-bisphosphatase (Fbp1)+ macrophages, accompanied downregulation inflammatory genes (Tnf), complement component 1, q subcomponent (C1q), but restoration repair collagenous (Marco) Cd36, importance compartments Moreover, distinct neutrophil subpopulations via platelet endothelial molecule (PECAM), CCL, CD80, interleukin 10 (IL-10) pathways, contributing 2). another an immune-epithelial restrain regeneration drivespost-acute sequelae corona virus disease 2019 (COVID-19) (PASC), suggesting diverse determining outcomes clinal consequences infections [13]. Immune metabolic function behavior tumor, inflammation, offer opportunities prevention related disorders. Ccr7+Ido1+ residing center phenotypically resembling mregDCs [14], evidence cues control identity fate mregDCs. Glycolysis upon CCR7 ligation supports CCR7-medited migration maintaining cytoskeleton rearrangement oligomerization, thereby supporting [15]. intermediate metabolite mevalonate pathway, farnesyl pyrophosphate (FPP), dLNs mitochondrial metabolism, consequently lead sustained germinal pathological [16]. expression tolerogenic DC2 (cDC2) producing tryptophan l-kynurenine, indispensable role metabolism controlling property cDCs [17]. Metabolic crosstalk emerges regulating DC-centered during Intra-tumoral glutamine supplementation support cDC1-mediated overcome therapeutic resistance immunotherapies [18]. melanoma-derived lactate serves trigger sterol element binding (SREBP2)-dependent activation cholesterol within TME, forming lactate-SREBP2 signaling axis driving maturation suppression immunity. DC-specific ablation inhibition SREBP2 exert effects promoting [19]. hyperglycaemia inhibit shifting composition subsets, most notably cDC1. increased glucose-to-acetyl-CoA induced alters global chromatin key DCs, metabolic-immune pathway orchestrating dysregulation [20]. intriguing identify whether glucose would affect its communications B sum, exhibit unique network CCR7-expressing cancer. These represent previously unrecognized dynamic establish surveillance homeostasis. issues biological function, regulation mechanism, remain largely unanswered worthy investigations future, examples, (1) developmental origin, functional specialization components; (2) governing initial formation, expansion, hub; (3) antigens signals determine polarization migratory DCs; (4) distribution characteristic other gastrointestinal tract, etc. Future exploration comprehensive spatiotemporal landscape understanding dictates development greatly facilitate based involved hub. integrative multi-omics analysis initiate paradigm-shifting transformation oncological provide resource scientific community understand diseases developing therapies future. Xuetao Cao Juan Liu conceived conceptualized concept this writing wrote original draft. Boyi generated figures table supervision Liu. All authors critically revised manuscript. Not applicable declare no conflicts interest. work supported Grants National Key R&D Program China (2023YFA1801400) Natural Science Foundation (92374115 82388201). applicable. Please note: publisher not responsible content functionality any information supplied authors. Any queries (other than missing content) directed corresponding author article.

Язык: Английский

Regulatory T Cell Infiltration-Driven Single-Cell Transcriptomic Analysis Identifies SAP18 as a Prognostic Marker for Esophageal Squamous Cell Carcinoma DOI
Jianxiang Huang,

Hanshuo Zhang,

Xinyue Lin

и другие.

Journal of Gastrointestinal Cancer, Год журнала: 2025, Номер 56(1)

Опубликована: Апрель 10, 2025

Язык: Английский

Процитировано

0

Immune microenvironment of tumor-draining lymph nodes: insights for immunotherapy DOI Creative Commons

J. Wei,

D. Li,

Haixia Long

и другие.

Frontiers in Immunology, Год журнала: 2025, Номер 16

Опубликована: Апрель 11, 2025

Tumor-draining lymph nodes (TDLNs) play a crucial role in modulating tumor immune responses and influencing the efficacy of immunotherapy. However, our current understanding microenvironment within these remains limited. Tumors not only impair anti-tumor activity CD8 + T cells by creating an immunosuppressive microenvironment, but they also facilitate evasion promote metastasis altering structure function TDLNs. Research has shown that tumor-specific memory (T TSM ) TDLNs are essential for checkpoint inhibitors, such as PD-1/PD-L1 blockers. Moreover, abnormal TDLNs, along with presence cells—such regulatory (Tregs), B (Bregs), dendritic (DCs)—contributes to tumor-mediated evasion. Therefore, gaining deeper is improving effectiveness immunotherapies developing novel therapeutic strategies. This review explores various TDLN-based strategies, addressing controversies surrounding node dissection, use source tumor-infiltrating lymphocytes (TILs) therapy, targeting methods reverse structural abnormalities These strategies offer valuable insights potential directions advancing

Язык: Английский

Процитировано

0

Protocol for multiplex immunofluorescence imaging of mouse intestinal tumors DOI
Shuqin Li,

Siyuan You,

Kairui Mao

и другие.

STAR Protocols, Год журнала: 2025, Номер 6(2), С. 103776 - 103776

Опубликована: Апрель 16, 2025

Язык: Английский

Процитировано

0

Construction of targeting GPR77+CD10+ lipid nanoparticles and validation of targeting capability in vitro and in vivo DOI Creative Commons
Junyue Fang, Qiongchao Jiang,

Xinyu Yang

и другие.

Current Research in Biotechnology, Год журнала: 2025, Номер unknown, С. 100291 - 100291

Опубликована: Апрель 1, 2025

Язык: Английский

Процитировано

0

Dendritic cells instruct T cell anti-tumor immunity and immunotherapy response DOI
Zhen Xiao, Jiajia Wang, Jingxing Yang

и другие.

The Innovation Medicine, Год журнала: 2025, Номер unknown, С. 100128 - 100128

Опубликована: Янв. 1, 2025

<p>Dendritic cells (DCs) are a heterogeneous population of antigen-presenting (APCs). They play pivotal roles in orchestrating innate and adaptive immune responses, particularly cancer. In tumor-draining lymph nodes (tdLNs), <i>de novo</i> priming occurs, where DCs present antigens to naive T cells, activating them initiating their clonal expansion. the tumor microenvironment (TME), intratumoral provide survival or co-stimulatory signals shape cell differentiation. However, scarcity dysfunctional states can greatly limit anti-tumor even be hijacked by tumor-related factors promote progression. Therefore, comprehensively understanding anti- pro-tumor activities is crucial. this review, we discuss ontogeny DC lineages emerging complexity states. Importantly, emphasize significant sustaining productive immunity. light these findings, also explore promising approaches for targeting boost immunity overcome resistance cancer immunotherapies. We propose that insights into rational design DC-based immunotherapeutic strategies against hold immense, underexploited potential.</p>

Язык: Английский

Процитировано

0

Tumor Vascular Occlusion by Calcium-based Thermosensitizer Provokes Continuous Cavitation Effect and Thermal Energy Transition Efficiency of Radiofrequency Ablation Therapy DOI

Guichun Zeng,

Xiayi Liang, Ling Yuan

и другие.

Biomaterials, Год журнала: 2024, Номер 315, С. 122944 - 122944

Опубликована: Ноя. 2, 2024

Язык: Английский

Процитировано

2

Perilymphatic regulatory T cell-dendritic cell interactions represent a novel axis of immunosuppression in cancer DOI
Carolina Mangana, Bárbara Maier

Cancer Cell, Год журнала: 2024, Номер 42(8), С. 1329 - 1331

Опубликована: Авг. 1, 2024

Язык: Английский

Процитировано

1

CD8+ T cells infiltrating into tumors were controlled by immune status of pulmonary lymph nodes and correlated with non-small cell lung cancer (NSCLC) patients’ prognosis treated with chemoimmunotherapy DOI Creative Commons

Zhexin Bai,

Xu Cheng,

Tianyu Ma

и другие.

Lung Cancer, Год журнала: 2024, Номер 197, С. 107991 - 107991

Опубликована: Окт. 16, 2024

Язык: Английский

Процитировано

0

Mapping intratumoral myeloid-T cell interactomes at single-cell resolution reveals targets for overcoming checkpoint inhibitor resistance DOI Creative Commons
Kate Bridges, Gabriela A. Pizzurro, Alev Baysoy

и другие.

bioRxiv (Cold Spring Harbor Laboratory), Год журнала: 2024, Номер unknown

Опубликована: Окт. 31, 2024

SUMMARY Effective cancer immunotherapies restore anti-tumor immunity by rewiring cell-cell communication. Treatment-induced changes in communication can be inferred from single-cell RNA-sequencing (scRNA-seq) data, but current methods do not effectively manage heterogeneity within cell types. Here we developed a computational approach to efficiently analyze scRNA-seq-derived, single-cell-resolved interactomes, which applied determine how agonistic CD40 (CD40ag) alters immune crosstalk alone, across tumor models, and combination with checkpoint blockade (ICB). Our analyses suggested that CD40ag improves responses ICB targeting both immuno-stimulatory immunosuppressive macrophage subsets communicating T cells, experimentally validated spatial basis for these immunofluorescence transcriptomics. Moreover, treatment established coordinated myeloid-T interaction hubs are critical reestablishing antitumor immunity. work advances the biological significance of hypotheses generated scRNA-seq-derived interactomes supports clinical translation myeloid-targeted therapies ICB-resistant tumors.

Язык: Английский

Процитировано

0

Association of artificial intelligence-based immunoscore with the efficacy of chemoimmunotherapy in patients with advanced non-squamous non-small cell lung cancer: a multicentre retrospective study DOI Creative Commons

Jiaqing Liu,

Dongchen Sun,

Shuoyu Xu

и другие.

Frontiers in Immunology, Год журнала: 2024, Номер 15

Опубликована: Ноя. 6, 2024

Purpose Currently, chemoimmunotherapy is effective only in a subset of patients with advanced non-squamous non-small cell lung cancer. Robust biomarkers for predicting the efficacy would be useful to identify who benefit from chemoimmunotherapy. The primary objective our study was develop an artificial intelligence-based immunoscore and evaluate value patho-immunoscore clinical outcomes cancer (NSCLC). Methods We have developed intelligence–powered analyzer based on 1,333 whole-slide images TCGA-LUAD. predictive model further validated CPTAC-LUAD cohort biomarker ORIENT-11 study, randomized, double-blind, phase 3 study. Finally, significance evaluated using cohort. Results Our achieved good accuracy all three mentioned above (TCGA-LUAD, mean AUC: 0.783; cohort, 0.741; 0.769). In 259 treated chemoimmunotherapy, those high (n = 146) showed significantly longer median progression-free survival than low 113) (13.8 months vs 7.13 months, hazard ratio [HR]: 0.53, 95% confidence interval [CI]: 0.38 – 0.73; p &lt; 0.001). contrast, no significant difference observed were chemotherapy (5.07 5.07 HR: 1.04, CI: 0.71 1.54; 0.83). Similar trends overall survival. Conclusion indicates that AI-powered applied LUAD digital slides can serve as NSCLC received This methodology could other cancers facilitate immunotherapy.

Язык: Английский

Процитировано

0